| Literature DB >> 28117716 |
Atallah F Ahmed1,2,3, Chia-Ruei Tsai4, Chiung-Yao Huang5, Sheng-Yang Wang6, Jyh-Horng Sheu7,8,9,10,11.
Abstract
New cembranoids klyflaccicembranols A-I (1-9), along with gibberosene D (10), have been isolated from the organic extract of a Formosan soft coral Klyxum flaccidum. Their structures were established by extensive spectroscopic analyses, including 2D NMR spectroscopy, and spectral data comparison with related structures. The cytotoxicity of the isolated metabolites, as well as their nitric oxide (NO) inhibitory activity, were evaluated and reported. Metabolites 2, 4, 6, 8 and 9 were found to exhibit variable activities against a limited panel of cancer cell lines in a range of IC50 16.5-49.4 μM. Among the tested cembranoids, compounds 4, 5, 6, and 9 significantly inhibited NO production in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages at a dose of 50 μg/mL.Entities:
Keywords: Klyxum flaccidum; NO inhibition; cembranoid; cytotoxicity; soft coral
Mesh:
Substances:
Year: 2017 PMID: 28117716 PMCID: PMC5295243 DOI: 10.3390/md15010023
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of cembranoids isolated from Klyxum flaccidum.
13C NMR spectral data of compounds 1–9.
| # | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 147.8 (C) | 147.7 (C) | 155.9 (C) | 146.3 (C) | 154.6 (C) | 80.9 (C) | 146.0 (C) | 147.4 (C) | 146.9 (C) |
| 2 | 121.0 (CH) | 121.2 (CH) | 67.2 (CH) | 124.3 (CH) | 122.7 (CH) | 129.2 (CH) | 123.7 (CH) | 121.2 (CH) | 120.8 (CH) |
| 3 | 89.7 (CH) | 91.1 (CH) | 126.3 (CH) | 136.2 (CH) | 70.7 (CH) | 138.0 (CH) | 138.3 (CH) | 89.1 (CH) | 121.0 (CH) |
| 4 | 74.2 (C) | 74.6 (C) | 137.6 (C) | 72.9 (C) | 75.2 (C) | 71.9 (C) | 73.0 (C) | 74.6 (C) | 136.6 (C) |
| 5 | 41.6 (CH2) | 40.5 (CH2) | 39.0 (CH2) | 45.5 (CH2) | 38.6 (CH2) | 43.8 (CH2) | 39.0 (CH2) | 41.3 (CH2) | 39.1 (CH2) |
| 6 | 22.1 (CH2) | 25.2 (CH2) | 24.2 (CH2) | 121.3 (CH) | 22.3 (CH2) | 22.3 (CH2) | 24.2 (CH2) | 21.8 (CH2) | 25.6 (CH2) |
| 7 | 127.0 (CH) | 64.6 (CH) | 125.2 (CH) | 141.4 (CH) | 127.0 (CH) | 128.6 (CH) | 127.6 (CH) | 126.3 (CH) | 126.5 (CH) |
| 8 | 132.1 (C) | 59.9 (C) | 133.2 (C) | 72.5 (C) | 133.9 (C) | 132.7 (C) | 131.9 (C) | 132.6 (C) | 133.8 (C) |
| 9 | 36.8 (CH2) | 36.7 (CH2) | 36.9 (CH2) | 43.6 (CH2) | 39.0 (CH2) | 39.0 (CH2) | 36.7 (CH2) | 36.8 (CH2) | 36.6 (CH2) |
| 10 | 25.1 (CH2) | 23.6 (CH2) | 24.3 (CH2) | 23.5 (CH2) | 24.2 (CH2) | 23.8 (CH2) | 24.3 (CH2) | 24.5 (CH2) | 24.8 (CH2) |
| 11 | 59.7 (CH) | 59.0 (CH) | 59.7 (CH) | 126.7 (CH) | 125.6 (CH) | 126.9 (CH) | 61.3 (CH) | 59.2 (CH) | 59.9 (CH) |
| 12 | 61.9 (C) | 60.3 (C) | 61.3 (C) | 132.8 (C) | 131.9 (C) | 136.1 (C) | 64.7 (C) | 60.4 (C) | 62.9 (C) |
| 13 | 72.8 (CH) | 71.9 (CH) | 71.6 (CH) | 37.3 (CH2) | 44.1 (CH2) | 36.1 (CH2) | 71.6 (CH) | 72.7 (CH) | 75.2 (CH) |
| 14 | 85.8 (CH) | 85.0 (CH) | 115.6 (CH) | 122.0 (CH) | 70.6 (CH) | 29.9 (CH2) | 122.9 (CH) | 84.9 (CH) | 68.1 (CH) |
| 15 | 26.6 (CH) | 25.7 (CH) | 27.6 (CH) | 31.6 (CH) | 27.8 (CH) | 75.1 (C) | 32.1 (CH) | 25.7 (CH) | 28.2 (CH) |
| 16 | 22.2 (CH3) | 20.9 (CH3) | 23.7 (CH3) | 22.6 (CH3) | 22.8 (CH3) | 24.5 (CH3) | 22.1 (CH3) | 22.2 (CH3) | 24.0 (CH3) |
| 17 | 21.2 (CH3) | 20.6 (CH3) | 24.5 (CH3) | 22.6 (CH3) | 23.5 (CH3) | 24.7 (CH3) | 22.3 (CH3) | 20.9 (CH3) | 25.4 (CH3) |
| 18 | 23.1 (CH3) | 22.2 (CH3) | 15.7 (CH3) | 29.7 (CH3) | 25.1 (CH3) | 27.8 (CH3) | 30.0 (CH3) | 22.6 (CH3) | 16.7 (CH3) |
| 19 | 16.7 (CH3) | 16.8 (CH3) | 15.2 (CH3) | 29.6 (CH3) | 15.1 (CH3) | 14.7 (CH3) | 15.1 (CH3) | 16.7 (CH3) | 15.2 (CH3) |
| 20 | 15.5 (CH3) | 16.0 (CH3) | 15.2 (CH3) | 17.6 (CH3) | 17.1 (CH3) | 14.8 (CH3) | 15.5 (CH3) | 16.0 (CH3) | 16.1 (CH3) |
| OAc | 169.9 (C) | 170.7 (C) | 169.9 (C) | ||||||
| 21.0 (CH3) | 21.1 (CH3) | 20.6 (CH3) |
Spectra recorded in C6D6 at 100 MHz; CDCl3 at 125 MHz; and CDCl3 at 100 MHz at 25 °C; Attached protons were determined by distortionless enhancement by polarization transfer (DEPT) experiments. Values are presented as ppm downfield from tetramethylsilane (TMS).
1H NMR spectral data for compounds 1–5.
| # | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| 2 | 5.59 br s | 5.65 br s | 5.70 d (10.0) | 6.19 d (16.4) | 5.41 d (7.6) |
| 3 | 4.61 d (4.8) | 4.78 d (5.0) | 5.25 d (10.0) | 5.83 d (16.4) | 4.34 d (7.6) |
| 5 | 1.48 m; 1.85, m | 1.82 m; 1.92 m | 2.10 m; 2.24 m | 2.31 2H, d (6.8) | 1.55 m; 1.86 m |
| 6 | 2.02 m; 2.15, m | 1.59 m; 1.86 m | 2.10 m; 2.27 m | 5.56 dd (15.6, 6.8) | 2.11 m; 2.34 m |
| 7 | 5.38 dd (5.2, 5.2) | 3.07 dd (6.0, 2.5) | 4.83 br d (6.0) | 5.52 d (15.6) | 4.99 dd (6.0, 6.0) |
| 9 | 2.04 m; 2.09 m | 2.10 m; 1.39 m | 2.16 m; 2.20 m | 1.58 m; 1.67 m | 1.98 m; 2.15 m |
| 10 | 1.76 m; 1.83 m | 1.54 m; 1.95 m | 1.61 m; 1.86 m | 2.01 m; 2.37 m | 2.14 m; 2.18 m |
| 11 | 3.15 dd (6.4, 2.0) | 2.98 d (7.5) | 2.47 dd (7.2, 2.0) | 5.11 dd (7.2, 7.2) | 4.93 dd (6.8, 6.0) |
| 13 | 3.58 br s | 5.21 s | 5.52 d (10.4) | 2.71 2H, d (8.0) | 2.27 m; 2.37 m |
| 14 | 4.78 br d (4.8) | 5.05 d (5.0) | 5.03 d (10.4) | 5.48 dd (8.0, 5.6) | 4.78 dd (5.6, 5.6) |
| 15 | 2.25 sept (6.8) | 2.17 m | 2.78 sept (6.8) | 2.53 sept (6.8) | 2.48 m |
| 16 | 0.94 3H, d (6.8) | 1.05 3H, d (6.5) | 1.05 3H, d (6.8) | 1.09 3H, d (6.8) | 1.06 3H, d (6.8) |
| 17 | 1.12 3H, d (6.8) | 1.10 3H, d (6.5) | 1.09 3H, d (6.8) | 1.10 3H, d (6.8) | 1.12 3H, d (6.8) |
| 18 | 0.98 3H, s | 1.05 3H, s | 1.80 3H, s | 1.27 3H, s | 1.14 3H, s |
| 19 | 1.48 3H, s | 1.24 3H, s | 1.55 3H, s | 1.16 3H, s | 1.55 3H, s |
| 20 | 1.18 3H, s | 1.42 3H, s | 1.22 3H, s | 1.60 3H, s | 1.68 3H, s |
| OAc | 1.91 3H, s | 2.10 3H, s |
Spectra recorded in C6D6, at 400 MHz; CDCl3 at 500 MHz; and CDCl3 at 400 MHz at 25 °C; J values (Hz) in parentheses.
Figure 2Correlation spectroscopy (COSY) and heteronuclear multiple bond correlation (HMBC) correlations in 1–8.
Figure 3Key nuclear Overhauser effect (NOE) correlations of 1, 8 and 2.
1H NMR spectral data for compounds 6–9.
| # | 6 | 7 | 8 | 9 |
|---|---|---|---|---|
| 2 | 5.61 d (16.0) | 6.24 d (16.0) | 5.60 br s | 6.25 d (11.2) |
| 3 | 6.10 d (16.0) | 5.75 d (16.0) | 4.57 d (5.2) | 5.85 d (11.2) |
| 5 | 1.51 m; 2.01 m | 2.10 m; 2.24 m | 1.63 m; 1.89 m | 2.00 2H, m |
| 6 | 2.22 m; 2.39 m | 2.10 m; 2.27 m | 2.16 m; 2.18 m | 1.97 m, 2.06 m |
| 7 | 5.34 dd (7.5, 7.5) | 5.03 dd (6.0, 6.0) | 5.36 dd (5.5, 5.5) | 5.03 dd (6.0, 6.0) |
| 9 | 1.95 m; 2.20 m | 2.16 m; 2.20 m | 2.04 m; 2.09 m | 1.95 m, 2.11 m |
| 10 | 2.07 m; 2.24 m | 1.61 m; 1.86 m | 1.76 m; 1.83 m | 1.43 2H, m |
| 11 | 5.19 br d (9.0) | 2.67 m | 2.89 dd (6.0, 3.6) | 3.08 dd (6.0, 6.0) |
| 13 | 2.13 m; 2.19 m | 4.59 dd (8.0, 8.0) | 5.16 d (2.0) | 3.72 d (6.0) |
| 14 | 1.63 m; 2.11 m | 5.10 d (8.0) | 5.00 dd (5.2, 2.0) | 4.60 d (6.0) |
| 15 | 2.52 m | 2.13 m | 2.76 m | |
| 16 | 1.21 3H, s | 1.04 3H, d (6.8) | 1.03 3H, d (6.8) | 1.06 d (6.8) |
| 17 | 1.13 3H, s | 1.07 3H, d (6.8) | 1.08 3H, d (6.8) | 1.28 d (6.8) |
| 18 | 1.40 3H, s | 1.35 3H, s | 1.00 3H, s | 1.59 3H, s |
| 19 | 1.62 3H, s | 1.60 3H, s | 1.59 3H, s | 1.32 3H, s |
| 20 | 1.67 3H, s | 1.42 3H, s | 1.39 3H, s | 1.34 3H, s |
| 15-OH | 2.60 s | |||
| 13-OH | 1.74 d (8.0) | |||
| OAc | 2.06 3H,s |
Spectra recorded in CDCl3 at 500 MHz; CDCl3 at 400 MHz; and C6D6 at 400 MHz at 25 °C; J values (Hz) in parentheses.
Figure 41H NMR chemical shift differences ∆δ (δS − δR) in ppm for the α-methoxy-α-(trifluoromethyl)phenylacetic (MTPA) esters of 1.
Figure 5Key NOE correlations of 3 and 4.
Figure 6Structures of semisynthetic cembranoid (11) and crassumol A (12).
Figure 7Key NOE correlations of 5–7.
Cytotoxicities (IC50 μM) of compounds 1–6 and 8–10.
| Compound | HT-29 | A549 | K562 | P388 |
|---|---|---|---|---|
| – | – | – | – | |
| – | 16.5 | 34.6 | – | |
| – | – | – | – | |
| – | – | 44.9 | – | |
| – | – | – | – | |
| – | 21.4 | – | – | |
| – | 49.4 | 47.4 | 34.6 | |
| 41.9 | – | – | 25.9 | |
| – | – | – | – | |
| Fluorouracil | 8.5 | 110 | 31.5 | 5.5 |
–: Compound was considered inactive when IC50 > 50 μM.
Figure 8Inhibitory effects of compounds 1–6 and 8–10 at 50 μg/mL on nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated RAW264.7 cells.